These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12521462)

  • 1. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 2. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting partial screening results: is it confusing and unsatisfactory?
    Mulvey S; Wallace EM
    Prenat Diagn; 2002 Jul; 22(7):633; author reply 633-4. PubMed ID: 12124702
    [No Abstract]   [Full Text] [Related]  

  • 5. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
    Rowe HJ; Fisher JR; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester Down syndrome screening: pregnant women's knowledge.
    Dahl K; Hvidman L; Jørgensen FS; Henriques C; Olesen F; Kjaergaard H; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
    Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of prenatal screening and psychological management of test decisions.
    Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and health professional acceptance of integrated serum screening for Down syndrome.
    Palomaki GE; Kloza EM; Haddow JE; Williams J; Knight GJ
    Semin Perinatol; 2005 Aug; 29(4):247-51. PubMed ID: 16104676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trial.
    Bekker HL; Hewison J; Thornton JG
    Prenat Diagn; 2004 Apr; 24(4):265-75. PubMed ID: 15065100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study.
    Fransen MP; Schoonen MH; Mackenbach JP; Steegers EA; de Koning HJ; Laudy JA; Galjaard RJ; Looman CW; Essink-Bot ML; Wildschut HI
    Prenat Diagn; 2010 Oct; 30(10):988-94. PubMed ID: 20799374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
    Jaques AM; Sheffield LJ; Halliday JL
    Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of the knowledge and attitudes of pregnant Thai women towards Down syndrome screening.
    Pruksanusak N; Suwanrath C; Kor-Anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Hanprasertpong T
    J Obstet Gynaecol Res; 2009 Oct; 35(5):876-81. PubMed ID: 20149035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome.
    Alberman E; Huttly W; Hennessy E; McIntosh A
    Prenat Diagn; 2003 Oct; 23(10):801-6. PubMed ID: 14558023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated serum screening for Down syndrome in primary obstetric practice.
    Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
    Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.